Bronx
Bronx Prevention Center
ICAP’s two research centers in New York, the Bronx Prevention Center and the Harlem Prevention Center, are hubs of research in New York City that have been historically underserved and disproportionately impacted by the HIV epidemic and, more recently, the COVID-19 epidemic. ICAP works with local community-based organizations, religious leaders, and advocates to promote community awareness of, and engagement with the research studies.


The Community Advisory Board (CAB) for the ICAP Clinical Trials Unit (CTU) provides guidance and feedback on proposed studies, outreach strategies, feedback on study materials, and information regarding community perceptions of the potential or current research studies.
Current studies include investigations of antibody-mediated prevention using broadly neutralizing antibodies (bnAbs) to prevent HIV or COVID-19, an injectable long-acting pre-exposure prophylaxis (PrEP) option, mobile technologies to improve PrEP adherence, integrated care for people who inject opiates, HIV vaccine studies, and studies of COVID-19 immunity, vaccine efficacy, and treatment among others.

Projects

HPTN 094: The INTEGRA Study
- current
HTPN 083: Give PrEP a Shot
- current
IMPOWER-022: The Merck Study
- current
Making PrEP Smart
- current
ICAP in Bronx
Program Start
2004
Key Technical Areas
- Clinical Research and Trials
- COVID-19 Research
- PreP Research
Current Funders
- National Institute of Health
- National Institute of Allergy and Infectious Diseases (NIH/NIAID)
Department of Health and Human Services (DHHS) - Family Health International (FHI)
- Fred Hutchinson Cancer Research Center
- National Institute of Allergy and Infectious Diseases (NIH/NIAID)
- AstraZeneca
- Merck
Site Leader
Ellen Morrison, MD, MPH
Dr. Ellen Morrison is the site lead and an investigator at the Bronx Prevention Center, a clinical research site that is one of the three sites that comprise the NIH-funded ICAP at Columbia Clinical Trials Unit. Dr. Morrison leads studies that focus on HIV prevention, including the use of pre-exposure prophylaxis and the provision of integrated services on a mobile van to engage out-of-care injection opiate users in HIV prevention and care. In addition, a rapid pivot to address the SARS-CoV-2 pandemic has included new projects on COVID-19 vaccines, testing of monoclonal antibodies, and other COVID-19 treatment modalities.
Jobs in the United States
See the ICAP careers page to search all job listings.